{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:06:18Z","timestamp":1789535178590,"version":"build-2803163510"},"reference-count":97,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["ES\/P000703\/1"],"award-info":[{"award-number":["ES\/P000703\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T025557\/1"],"award-info":[{"award-number":["MR\/T025557\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Despite the well\u2010documented benefits of opioid substitution treatment (OST) in treating opioid dependence (OD), many people diagnosed with OD desire to live a drug\u2010free life. The transition to abstinence involves detoxification: a gradual dose reduction of OST to zero milligrams. Despite these aspirations, only a minority of patients undertake detoxification, and successful completion remains limited. This mixed\u2010methods systematic review aimed to identify the barriers and facilitators to detoxification from OST, to help provide a better understanding of what can be done to support patients and improve outcomes in OD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Four databases were searched until 22 January 2025: PubMed, Embase, APA PsycINFO and CINAHL. Qualitative, quantitative and mixed methods studies of individuals with a diagnosis of OD undergoing detoxification from OST, or staff responsible for providing the treatment, were included. Studies of only pharmacological interventions were excluded. An integrated approach to data synthesis was used, transforming quantitative data into textual descriptions to integrate them with qualitative data and form one set of themes. Joanna Briggs Institute checklists were used to assess the quality of included papers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1999 studies identified, 41 papers were deemed eligible. Studies originated from the USA (22), UK (7), Sweden (6), Canada (1), Ireland (1), Norway (1), Switzerland (1), Australia (1) and China (1). The medications explored included methadone (28), buprenorphine (5), both forms (6) and unspecified OST (2). Studies were conducted in outpatient settings (29), inpatient settings (7), mixed settings (4) and a prison setting (1). Participants included patients (37), treatment providers (1) and mixed populations (3). Factors affecting detoxification were present at an individual and structural level, with overlap between influences at the initiation and completion phases. Eight themes emerged, comprising psychological and emotional factors (particularly around fear of detoxification), personal motivation, withdrawal symptoms, clinical and demographic factors, environmental factors, social factors, professional support and treatment models\/interventions. 54% of included studies were rated high quality, and 37% of medium quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Detoxification from opioid substitution treatment appears to be commonly hindered by fear, emotional resurgence, low confidence, environmental turbulence, negative social influences and insufficient professional\/pharmacological support, while facilitators include psychological readiness, life stability, supportive relationships, psychological interventions, inpatient facilities and adjunctive medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.70482","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:01:52Z","timestamp":1781740912000},"page":"2607-2619","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Barriers and facilitators to detoxification from opioid substitution treatment: A mixed\u2010methods systematic review"],"prefix":"10.1111","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6485-3286","authenticated-orcid":false,"given":"Amy","family":"Bagshaw","sequence":"first","affiliation":[{"name":"Division of Psychiatry, Department of Brain Sciences Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Department of Brain Sciences Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"India","family":"Olchefske","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Department of Brain Sciences Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M.","family":"Paterson","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Department of Brain Sciences Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike J.","family":"Crawford","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Department of Brain Sciences Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4512-3453","authenticated-orcid":false,"given":"Anne","family":"Lingford\u2010Hughes","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, Department of Brain Sciences Imperial College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15636"},{"key":"e_1_2_11_3_1","volume-title":"Opioid Use Disorder: Evaluation and Management","author":"Dydyk AM","year":"2025"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232086"},{"issue":"1","key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds","volume":"3","author":"Whelan PJ","year":"2012","journal-title":"J Neurosci Rural Pract"},{"key":"e_1_2_11_6_1","unstructured":"World Health Organisation.Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence [Internet]. World Health Organisation;2009[cited 2025]. Available from:https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/6e13bd2e\u20104c56\u20104a39\u2010b69b\u20105bfa96d933f1\/content"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/08897077231165625"},{"key":"e_1_2_11_9_1","unstructured":"Public Health England.Part 4: supporting opioid detoxification. Opioid substitution treatment: guide for keyworkers. [Internet] GOVUK;2021[cited 2025]. Available from:https:\/\/www.gov.uk\/government\/publications\/opioid\u2010substitution\u2010treatment\u2010guide\u2010for\u2010keyworkers\/part\u20104\u2010supporting\u2010opioid\u2010detoxification"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659890903531246"},{"issue":"7","key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jama.1973.03230070013002","article-title":"Detoxification of rehabilitated methadone\u2010maintained patients","volume":"226","author":"Cushman P","year":"1973","journal-title":"JAMA\u2010J Am Med Assoc"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000049486"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12884"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03870.x"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.11.007"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6539.103"},{"issue":"2","key":"e_1_2_11_17_1","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato L","year":"2013","journal-title":"Cochrane Db Syst Rev"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000141641"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952997409011032"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.3.423"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.161.5.654"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770150119014"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2021.07.010"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.03.014"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.05.033"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.4103\/0972-6748.119652"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12245"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-018-0685-1"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03090080008002"},{"key":"e_1_2_11_30_1","unstructured":"Covidence. [Internet]. Veritas Health Innovation; n.d. [cited 2025]. Available from:https:\/\/www.covidence.org\/"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-017-0454-2"},{"key":"e_1_2_11_32_1","unstructured":"The Joanna Briggs Institute.Critical Appraisal Tools [Internet]. Adelaide (SA): The Joanna Briggs Institute;2024[cited 2025]. Available from:https:\/\/jbi.global\/critical-appraisal-tools"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(87)80013-2"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826087309033105"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/11782218221107021"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.08.001"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(88)90037-2"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.7.1031"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2014.941085"},{"issue":"4","key":"e_1_2_11_40_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/10826087609056176","article-title":"21\u2010Day outpatient methadone detoxification \u2010 Evaluation","volume":"11","author":"Kahn RB","year":"1976","journal-title":"Int J Addict"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-11859-3"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078345816634079"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.12.006"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2010.503904"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826089509105138"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13264"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000584"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826087509027340"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.3109\/10550499709137021"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(87)90002-5"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826087909060372"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23-2721"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0376-8716(99)00063-0"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-010-0469-3"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01858.x"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1978.tb16774.x"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/965267"},{"key":"e_1_2_11_58_1","first-page":"482","article-title":"Techniques of withdrawal from methadone and their outcome over six months to two years","volume":"1","author":"Chappel JN","year":"1973","journal-title":"Proc Natl Conf Methadone Treat"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1037\/\/0022-006x.65.5.803"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.04200030101016"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1159\/000019022"},{"key":"e_1_2_11_62_1","unstructured":"BlackC.Review of drugs part two: prevention treatment and recovery [Internet]. GOV.UK2021 [cited 2025]. Available from:https:\/\/www.gov.uk\/government\/publications\/review\u2010of\u2010drugs\u2010phase\u2010two\u2010report\/review\u2010of\u2010drugs\u2010part\u2010two\u2010prevention\u2010treatment\u2010and\u2010recovery"},{"key":"e_1_2_11_63_1","unstructured":"NHS England.Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms: Framework for action for integrated care boards (ICBs) and primary care [Internet]. London: NHS England;2013[cited 2025]. Available from:https:\/\/www.england.nhs.uk\/long-read\/optimising-personalised-care-for-adults-prescribed-medicines-associated-with-dependence-or-withdrawal-symptoms\/"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20180022"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.68.3.438"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/camh.12671"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.2810"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.10.010"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0493-y"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15647"},{"key":"e_1_2_11_71_1","unstructured":"Office for Health Improvement and Disparities.Adult substance misuse treatment statistics 2023 to 2024: report [Internet]. GOV.UK;2024[cited 2025]. Available from:https:\/\/www.gov.uk\/government\/statistics\/substance\u2010misuse\u2010treatment\u2010for\u2010adults\u2010statistics\u20102023\u2010to\u20102024\/adult\u2010substance\u2010misuse\u2010treatment\u2010statistics\u20102023\u2010to\u20102024\u2010report"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmod.2009.04.002"},{"key":"e_1_2_11_73_1","unstructured":"National Collaborating Centre for Mental Health (UK).Drug Misuse: Opioid Detoxification [Internet]. National Institute for Health and Care Excellence (NICE);2008[cited 2025]. Available from:https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK50622\/#:~:text=The%20guideline%20on%20Drug%20misuse treatment%20and%20care%2C%20and%20to"},{"key":"e_1_2_11_74_1","unstructured":"NHS England.Capability framework for the drug and alcohol treatment and recovery workforce [Internet]. London: NHS England;2025[cited 2025]. Available from:https:\/\/www.england.nhs.uk\/long\u2010read\/capability\u2010framework\u2010for\u2010the\u2010drug\u2010and\u2010alcohol\u2010treatment\u2010and\u2010recovery\u2010workforce\/"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2018.1475319"},{"key":"e_1_2_11_76_1","unstructured":"NHS England.10\u2010year strategic plan for the drug and alcohol treatment and recoveryworkforce (2024\u20132034) [Internet]. London: NHS England;2024[cited 2025]. Available from:https:\/\/www.england.nhs.uk\/statistics\/wp\u2010content\/uploads\/2024\/05\/PRN00937\u201010\u2010year\u2010strategic\u2010plan\u2010for\u2010the\u2010drug\u2010and\u2010alcohol\u2010treatment\u2010and\u2010recovery\u2010workforce\u20102024\u2010to\u20102034.pdf"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.653426"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06821-9"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000474"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.02.020"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/21556660.2019.1704416"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.64719\/pb.4615"},{"key":"e_1_2_11_83_1","unstructured":"Turning Point.Written evidence submitted by Turning Point to the Public Accounts Committee [Internet]. UK Parliament;2023[cited 2025]. Available from:https:\/\/committees.parliament.uk\/writtenevidence\/118662\/html\/"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108367"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2017.1356792"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/scan\/nsab029"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00252-8"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.124768.2"},{"key":"e_1_2_11_89_1","unstructured":"Substance Abuse and Mental Health Services Administration.Substance Abuse Treatment: Group Therapy. Rockville (MD): Substance Abuse and Mental Health Services Administration;2005[cited 2025]. Available from:https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64220\/"},{"issue":"2","key":"e_1_2_11_90_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/bjsw\/bcad236","article-title":"Role of peer support in building motivation to change addictive behaviour","volume":"54","author":"Ctvrteckov\u00e1 M","year":"2024","journal-title":"Brit J Soc Work"},{"key":"e_1_2_11_91_1","unstructured":"Office for Health Improvement and Disparities.Part 1: introducing recovery peer support and lived experience initiatives [Internet]. GOVUK;2025[updated 16 May 2025; cited 2025]. Available from:https:\/\/www.gov.uk\/government\/publications\/recovery-support-services-and-lived-experience-initiatives\/part-1-introducing-recovery-peer-support-and-lived-experience-initiatives"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08656-1"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13062"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(94)00080-I"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-100101856"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(86)90080-3"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.12.4.262"},{"key":"e_1_2_11_98_1","unstructured":"Office for Health Improvement and Disparities.Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2017 to 31 March 2018. [Internet]. Public Health England;2018[cited 2025]. Available from:https:\/\/assets.publishing.service.gov.uk\/media\/5bd9d48040f0b604ce5c9d28\/AdultSubstanceMisuseStatisticsfromNDTMS2017\u201018.pdf"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70482","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.70482","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:00:39Z","timestamp":1789534839000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.70482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":97,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/add.70482"],"URL":"https:\/\/doi.org\/10.1111\/add.70482","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"2025-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}